Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Arif N, Ali"'
Autor:
Mustafa Abugideiri, Eduard Schreibmann, Jeffrey Switchenko, Mark W. McDonald, Jonathan J. Beitler, Walter J. Curran, Deborah Bruner, Pretesh Patel, Wondemagegnhu Tigeneh, Miressa Mijena, Sibo Tian, Anees Dhabaan, Natia Esiashvili, Tian Liu, Arif N. Ali
Publikováno v:
Journal of Global Oncology, Vol 5, Pp 1-16 (2019)
PURPOSE: Transitioning from two-dimensional to three-dimensional treatment planning requires developing contouring skills. Contouring atlases are excellent resources, but they do not provide users active feedback. Developing countries may not have ma
Externí odkaz:
https://doaj.org/article/5e2fdc4fd357411ba8da81a45c2246a4
Autor:
Christina I. Tsien, Stephanie L. Pugh, Adam P. Dicker, Jeffrey J. Raizer, Martha M. Matuszak, Enrico C. Lallana, Jiayi Huang, Ozer Algan, Nimisha Deb, Lorraine Portelance, John L. Villano, John T. Hamm, Kevin S. Oh, Arif N. Ali, Michelle M. Kim, Scott M. Lindhorst, Minesh P. Mehta
PURPOSE To assess whether reirradiation (re-RT) and concurrent bevacizumab (BEV) improve overall survival (OS) and/or progression-free survival (PFS), compared with BEV alone in recurrent glioblastoma (GBM). The primary objective was OS, and secondar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a4c03b0f137d718334db45ae38b7cb4
https://www.zora.uzh.ch/id/eprint/228975/
https://www.zora.uzh.ch/id/eprint/228975/
Autor:
Katherine B. Kelly, Joel G. Fletcher, Arif N. Ali, Rich Rana, Joseph D. Novak, Shweta Khankari, Abraham H. Dachman, Michael P. Zintsmaster, Adnan Qalbani
Publikováno v:
Radiology. 249:167-177
To introduce an educational intervention-specifically, a specialized training course-and perform a formative evaluation of the effect of the intervention on novice reader interpretation of computed tomography (CT) colonographic data.The study was ins
Autor:
Paulo Abdo do Seixo Kadri, Matthew A. Adamo, Jennifer Adamski, Osama Al-Mefty, Arif N. Ali, Kristian Aquilina, James A. Balogun, Garni Barkhoudarian, Ute Bartels, Wenya Linda Bi, Eric Bouffet, Julie A. Bradley, Henry Brem, Paolo Cappabianca, Ricardo L. Carrau, William T. Couldwell, Walter J. Curran, Maria Laura Del Basso De Caro, Dale Ding, Alberto Di Somma, Leo F.S. Ditzel Filho, Brian J. Dlouhy, Ian F. Dunn, James J. Evans, Manuel Ferreira, David P. Friedman, Takeshi Funaki, Ashish R. Gandhe, Ravi H. Gandhi, M. Reid Gooch, Daniel J. Indelicato, George Jallo, Ali O. Jamshidi, John Jane, Rachel Jimenez, David Jones, Daniel F. Kelly, Tyler J. Kenning, Edward E. Kerr, Irene Kim, Anne Klibanski, Douglas Kondziolka, Khaled M. Krisht, Edward R. Laws, Cheng-Chia Lee, Robert G. Louis, L. Dade Lunsford, Shannon M. MacDonald, Alessandra Mantovani, Konstantinos Margetis, Luigi Maria Cavallo, Carolina Martins, Heather J. McCrea, Gautam U. Mehta, Edward A. Monaco, Hermann L. Müller, Ajay Niranjan, Guilian Niu, Edward H. Oldfield, Bradley A. Otto, Troy D. Payner, Maria Peris-Celda, Carlos D. Pinheiro-Neto, Daniel M. Prevedello, Jiang Qian, Albert L. Rhoton, Benjamin A. Rubin, James T. Rutka, Theodore H. Schwartz, Laligam N. Sekhar, Robert C. Sergott, Roshan V. Sethi, Jason P. Sheehan, Eugenia Shekhtman, Walavan Sivakumar, Domenico Solari, Mark Souweidane, Zachary Tempel, Charles Teo, Philip V. Theodosopoulos, Dominic Thompson, Nicholas A. Tritos, Rafael Uribe, Rowan Valentine, Hung Tzu Wen, Jeffrey H. Wisoff, Anthony T. Yachnis, Tong Yang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9993add745ccfe4cfe47ed6bbce3d12e
https://doi.org/10.1016/b978-0-12-416706-3.01002-3
https://doi.org/10.1016/b978-0-12-416706-3.01002-3
Autor:
Jim, Zhong, Arif N, Ali, Alfredo D, Voloschin, Yuan, Liu, Walter J, Curran, Ian R, Crocker, Hui-Kuo G, Shu
Publikováno v:
Cancer. 121(9)
Bevacizumab is a monoclonal antibody targeting vascular endothelial growth factor and is approved for the treatment of patients with recurrent glioblastoma (GBM). Previous authors have reported differential response to bevacizumab on an individual ba
Publikováno v:
Cancer. 118(9)
To compare the characteristics and outcome of adults and children diagnosed with Wilms' tumor.The Surveillance, Epidemiology and End Results (SEER) database was analyzed for patients diagnosed with Wilms' tumor between 1973 and 2007. Patients were st